PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2021.8432022543782-792Selection Strategies and Practical Application of BRAF V600E-Mutated Non–Small Cell Lung CarcinomaInwoo Hwang, Yoon-La Choi, Hyunwoo Lee, Soohyun Hwang, Boram Lee, Hobin Yang, Chaithanya Chelakkot, Joungho Hanhttp://e-crt.org/upload/pdf/crt-2021-843.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2021.843, http://e-crt.org/upload/pdf/crt-2021-843.pdf
Cancer Cytopathology10.1002/cncy.226482022Assessment of BRAF V600E (VE1) immunochemistry for the detection of BRAF V600E mutation in non–small cell lung carcinoma cytology specimensAshley Garcia, Maria Del Mar Rivera Rolon, Bedia Barkoh, Wei Chen, Rajyalakhsmi Luthra, Sinchita Roy‐Chowdhurihttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cncy.22648, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cncy.22648, https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncy.22648
Clinical Lung Cancer10.1016/j.cllc.2016.11.0012017183e211-e213Durable Response to Combination of Dabrafenib and Trametinib in BRAF V600E-Mutated Non–small-cell Lung CancerLeah M. Pervere, Sagar Rakshit, Alexa B. Schrock, Vincent A. Miller, Siraj M. Ali, Vamsidhar Velchetihttps://api.elsevier.com/content/article/PII:S1525730416303540?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730416303540?httpAccept=text/plain
10.21203/rs.3.rs-323942/v12021Gastrointestinal perforation following dabrafenib and trametinib administration in non-small cell lung carcinoma with BRAF V600E mutation: a case report and literature reviewYuri Shimada, Yuki Sato, Ryo Tachikawa, Shigeo Hara, Keisuke Tomiihttps://www.researchsquare.com/article/rs-323942/v1, https://www.researchsquare.com/article/rs-323942/v1.html
Investigational New Drugs10.1007/s10637-021-01166-72021401190-193Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case reportFrancesco Gelsomino, Alessandro Di Federico, Maria Lucia Tardio, Giada Grilli, Antonietta D’Errico, Andrea Ardizzoni, Stefania Salvagnihttps://link.springer.com/content/pdf/10.1007/s10637-021-01166-7.pdf, https://link.springer.com/article/10.1007/s10637-021-01166-7/fulltext.html, https://link.springer.com/content/pdf/10.1007/s10637-021-01166-7.pdf
Clinical Drug Investigation10.1007/s40261-019-00823-3201939101003-1007Dabrafenib Plus Trametinib for BRAF V600E-Mutant Non-small Cell Lung Cancer: A Patient Case ReportJanet Panhttp://link.springer.com/content/pdf/10.1007/s40261-019-00823-3.pdf, http://link.springer.com/article/10.1007/s40261-019-00823-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40261-019-00823-3.pdf
Chest10.1016/j.chest.2017.08.69420171524A664BRAF Mutated Tall Cell Papillary Carcinoma Lung Metastasis Following ThyroidectomyBrandon Hookshttps://api.elsevier.com/content/article/PII:S0012369217322122?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0012369217322122?httpAccept=text/plain
Cancer Genetics10.1016/j.cancergen.2015.04.00120152086351-354BRAF V600E mutations: a series of case reports in patients with non–small cell lung cancerJamie M. Goldman, Jhanelle E. Grayhttps://api.elsevier.com/content/article/PII:S2210776215000435?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2210776215000435?httpAccept=text/plain
Leong's Manual of Diagnostic Antibodies for Immunohistology10.1017/9781139939508.1532016319-320Mutated BRAF V600Ehttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/9E5CBFCFAF0482FDAB2FB20BACB5D17E
Respirology10.1111/resp.13420_569201823295-295REAL-WORLD CLINICAL OUTCOMES AND PATHOLOGIC FEATURES OF BRAF V600E-MUTATED LUNG ADENOCARCINOMA PATIENTS IN TAIWANhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fresp.13420_569, http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13420_569/fullpdf